Search Results
Critical evaluation of Quality Control procedures for actinium 225 radiopharmaceuticals
Actinium-225 |Q & A session with the Experts | Dr. N. Ramamoorthy, Sr. Advisor to Director, BARC
A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC patients
2021 Actinium-225 User Group Meeting - DOE Isotope Program
2019-2021 D.F. Torgerson Award: Actinium-225 Production Team
Actinium-225 Spotlight: Nurturing Targeted Alpha Therapy from Production to Patient Care and Beyond
Future of Nuclear Medicine in Treatment of NETs (Actinium 225) - Dr. Philip Cohen (Nuclear Medicine)
2020 Actinium-225 User Group Meeting - DOE Isotope Program
Check out full article in bio 🙏🙏
Phase I dose-escalation study of fractionated dose 225Ac J591 for mCRPC
From design to radiolabelling - understanding the radiochemistry
Radiopharmaceuticals: Established Evidence and Process of Implementation of a Theranostics Program
